Share Forum - Discuss JSE shares and join the Investor Challenge

I am fortunate, my broker is also linked to me on steam, gaming software for online games, currently playing Advanced warfare ...  lol ... but he is also my firewall when it comes to stupid decisions. Let's face it, I know my job I do everyday, but he know more about investments and companies, as he is a stock broker, they do research and have people doing it for them.

Understood, thanks for reply.

If you buy a share, say 1000 off, and there is only 800 available at a price, you must be able to see what the next 200 will cost you.  But will have a look at what is available.

My site shows there is 3843 AVL shares available at R2.10  , and I want to buy 5000, thus I need to see what the other shares will cost me.

Yes, my actual portfolio is live. But I am looking at following shares live, where it give u live the 3 top buyers and 3 top sellers - prices

Did, but in says the following. "Sorry, you do not have access to this service "  , mailed the Darkside, they will phone me. Am willing to pay. Were is MoneyPenny....

What is that ?

P/E Ratio   43.86

Release Date: 24/02/2015

UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE SIX
MONTHS ENDED 31 DECEMBER 2014


CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

                                                 Unaudited    Unaudited       Audited
                                                 Six months   Six months   Year ended
                                                  31-Dec-14    31-Dec-13   30-June-14
                                                      R’000        R’000         R’000
Current assets                                     158 961       49 759       164 997
Cash and cash equivalents                          141 154       40 239       143 883
Total assets                                       258 317      100 486       247 535
Total equity and liabilities                       258 317      100 486       247 535
Net asset value per share (cents)                    92.31        55.62         89.00
Net tangible asset value per share (cents)           76.19        55.25         80.30

Revenue                                              92 721      74 677       155 791
Gross profit                                         50 755      37 588        84 348
Earnings per share (cents)                           2.33        4.17          6.44
Diluted earnings per share (cents)                   2.33        4.17          6.44

Notes to the statement of comprehensive income
Headline earnings for the period attributable to ordinary
shareholders:
Headline earnings per share (cents)                  2.33         4.17         6.44
Diluted headline earnings per share (cents)          2.33         4.17         6.44
- Total number of shares in issue(‘000)              221 843      90 467       211 615
- Weighted average number of shares (‘000)           221 615      90 467       120 272
- Diluted weighted average number of shares (‘000)   221 843      90 467       120 273
Reconciliation of headline earnings calculation:
Earnings for the period attributable to ordinary     5 174        3 776        7 740
shareholders
Headline earnings for the period attributable to ordinary     
                     5 174       3 776        7 740
shareholders
Cash and cash equivalents at end of year             141 154      40 239       143 883

REVENUE

SOUTH AFRICA                                         13 001         -           7 259
   External revenue                                  13 001         -           7 259

 AUSTRALIA                                           79 720       74 677     148 532
   External revenue                                  79 720      74 677      148 532


During the period under review the company entered into an agreement to develop five day hospitals, one in Gauteng and four in the Western Cape. Construction has commenced on some of these day clinics. The acquisition consideration was settled through the issue of 10 000 000 new shares at an issue price of R1.70 per share.

In Australia, construction of the largest ophthalmic day hospital in the country has commenced. The
six-theatre facility is scheduled for completion towards the end of 2015.

Sundry negotiations with different role players within the day hospital environment are ongoing
and, if successful, will provide Presmed Australia with an improved coverage of specialised day
hospitals in the greater Sydney area. The above initiatives will add further growth opportunities for
the Australian subsidiaries.

The South African activities were focussed mainly on transactions to develop additional day
hospitals, which will be achieved through negotiations with like-minded partners, as outlined in the
pre-listing prospectus.

Management is confident that, by the end of June 2016, the South African subsidiary will be in
control of at least nine day hospitals compared to the current two operational units.

Projects in the pipeline for South Africa include:
- Advanced Durbanville Surgical Centre (under construction, operational Q3 2015);
- Advanced Panorama Surgical Centre (under construction, operational Q1 2016);
- Advanced Soweto Day Hospital (under construction, operational Q1 2016);
- Advanced Knysna Surgical Centre (construction Q1 2015, operational Q1 2016);
- Advanced Waterkloof Somerset Surgical Centre (construction Q1 2015, operational Q1 2016);
- Advanced Worcester Surgical Centre (construction Q1 2015, operational Q1 2016)
- Advanced Groenkloof Surgical Centre (construction Q4 2015, operational Q1 2016)

It should be noted that the R100 million cash raised in conjunction with the listing is held for future
developments which will only start generating income for the group in the next financial year.

Thanks